Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

More Press Releases

Asian shares edge higher with Fed meeting in focus

Dec 17, 2018

SINGAPORE — Asian markets rose Monday on hopes that the Federal Reserve would re-evaluate its hawkish stance at a meeting later this week, following signs of slower global growth. KEEPING SCORE: Japan's Nikkei 225 index added 0.8 percent to 21,536.85 and the Kospi in South Korea gained 0.3 percent to 2,074.51. Hong Kong's Hang Seng was up 0.3 percent at 26,178.87. The Shanghai Composite index rose 0.1 percent to 2,597.22. Australia's S&P ASX 200 was 0.6 percent higher at 5,635.50. Shares were higher in Taiwan and Singapore but fell in Indonesia. WALL STREET: On Friday, weak economic data from China...

Lebanese take to the streets to protest political stalemate

Dec 17, 2018

BEIRUT — Hundreds of Lebanese took to the streets Sunday to protest against a political stalemate that has prevented the formation of a new government seven months after elections. The demonstration in Beirut was organized by the Communist Party but drew others frustrated by the country's deepening political and economic crisis. Wearing red scarves and raising red flags, protesters complained about corruption, poor public services and spiraling public debt that is more than 150 percent of GDP. One banner reads: "Off to the streets: enough talk. " Protester Osama Assad said failure to form the government only "doubles the risks."...

Westbrook, Murray tussle as Nuggets beat Thunder 109-98

Dec 17, 2018

DENVER — For all his offensive contributions and rebounding, Nikola Jokic's most important role in the end was peacemaker. Jokic scored 24 points, Jamal Murray had 19 and the Denver Nuggets beat the Oklahoma City Thunder 109-98 on Friday night after Murray and Russell Westbrook had a heated exchange. Westbrook and Murray pushed each other and argued after lining up next to each other for a jump ball in the final seconds. Jokic tried to get between them, and Westbrook threatened to beat up Jokic while being restrained. No blows were exchanged, but the final moments played out amid heightened...

Stocks plunge to 8-month lows on growth fears; J&J nosedives

Dec 17, 2018

NEW YORK — Stocks staggered to eight-month lows Friday after weak economic data from China and Europe set off more worries about the global economy. Mounting tensions in Europe over Britain's impending departure from the European Union also darkened traders' moods. Major U.S. indexes fell about 2 percent and the Dow Jones Industrial Average dropped as much as 563 points. On the benchmark S&P 500 index, health care and technology companies absorbed the worst losses. Johnson & Johnson plunged by the most in 16 years after Reuters reported that the company has known since the 1970s that its talc Baby...

Markets Right Now: S&P 500 sinks to lowest level since April

Dec 17, 2018

NEW YORK — The latest on developments in financial markets (all times local): 4 p.m. Stocks ended the week with a steep loss on Wall Street as the S&P 500 dropped to its lowest level since April. The benchmark index is now down almost 3 percent for the year. New concerns about slowing growth in China as well as growing disarray surrounding plans for Britain to exit the European Union put investors in a mood to sell Friday. Johnson & Johnson plunged 10 percent after Reuters reported that the company has known since the 1970s that its talc baby powder...

Subscribe to our newsletter!

Your Name

Your Email Address